You are here: Introduction > Contra-indications, warnings, etc
 
        PreviousNext
 
Metacam 1.5 mg/ml Oral Suspension for Dogs:  Contra-indications, warnings, etc
 
 
Metacam 1.5 mg/ml Oral Suspension for Dogs
Contra-indications, warnings, etc
Do not use in pregnant or lactating animals, as the safety of the product has not been established in these categories of animals.
Do not use in animals suffering from gastro-intestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. Do not use in case of hypersensitivy to the active substance or to any of the excipients.
Do not use in dogs less than 6 weeks of age.
Typical adverse drug reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood , apathy and renal failure have occasionally been reported. These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity. This product for dogs should not be used in cats as it is not suitable for use in this species. In cats, Metacam 0.5 mg/ml Oral Suspension for Cats should be used.
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. Metacam must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacokinetic properties of the products used previously.
In case of overdose, symptomatic treatment should be initiated.
User precautions
Individuals sensitive to NSAIDs should avoid contact with the product. In case of accidental self-administration, seek medical advice immediately and show the package insert or label to the Doctor.
Any unused product or waste materials should be disposed or in accordance with national requirements for pharmaceutical products.
For animal treatment only.
Keep out of reach of children.
           
 
        PreviousNext
  Date updated: 9 April 2008